top of page

4 Medical Discoveries That Changed How Scientists Understand Autism

Writer: Timothy Agnew
Timothy Agnew
Nov 5, 2024
6 min read

Updated: 3 days ago

What 4 studies from 2023 revealed about where autism comes from, and what they don't show yet.


Updated November 18, 2026, with current evidence and references.


Autism research illustration

This article is an addendum to my book, Invisible Parents: Hidden Secrets of Special Needs Parents: A Book of Hope. My aim is to keep special needs parents current on autism research.


Autism is more common than it once seemed. A 2022 global review of studies published since 2012 put the median prevalence worldwide at about 1 in 100. US numbers run higher. In the CDC's most recent report, covering 2022, about 1 in 31 children aged 8 years at 16 US sites had been identified with autism spectrum disorder (ASD).


When your child is first diagnosed, it can be an isolating time, full of confusion and sometimes denial. One of the most useful things a parent can do is stay current with the research. It helps you separate real progress from hype, and it connects you to a large autism community.


The 4 studies below, all published in 2023, changed how scientists think about where autism comes from. None of them is a treatment yet. Each one points to where treatments may eventually come from, and I've noted what has happened since.


1. Memory and the autistic brain


Neuroscientists at Trinity College Dublin studied infantile amnesia in mice. Infantile amnesia is the reason none of us remember the first few years of life.


The team used a mouse model in which the mother's immune system is activated during pregnancy. In humans, infection during pregnancy is one of many factors linked to a higher chance of autism. Male offspring in this model did not show infantile amnesia: they kept memories that typical mice lose.


The researchers also showed that "forgotten" infant memories are still stored. By reactivating specific memory cells with light, they brought those memories back in typical mice, and in some experiments the memories stayed restored.


What it means: forgetting in early life seems to be a reversible retrieval problem, and the immune environment during development can switch it on or off. This is mouse work. It does not show that autistic children remember infancy. The same lab has since linked the effect to microglia, the brain's immune cells, again in mice.


2. The gut-brain connection


A 2023 study in Nature Neuroscience took on a long-running problem: gut microbiome studies in autism kept contradicting each other.


The researchers built a new statistical method and applied it to 10 existing microbiome datasets plus 15 others covering diet, metabolites, immune markers, and brain gene expression. They found a consistent pattern of gut microbes and metabolites linked to autism traits, along with restrictive eating and inflammatory immune markers.


There's an important caveat. The pattern showed up when autistic children were compared with unrelated children of the same age and sex. It did not show up when they were compared with their own siblings.


That fits a large 2021 Australian study in Cell of 247 people. It found almost no direct link between an autism diagnosis and the microbiome. Instead, restricted interests led to less varied diets, which led to less diverse gut bacteria. In other words, some of the gut differences may be a result of autism-related eating, not a cause of autism.


The gut matters either way. Gastrointestinal problems are common in autistic people and worth treating. Placebo-controlled trials of fecal microbiota transplant are underway, such as the Gut Bugs in Autism Trial in adolescents and adults, but it is not an established treatment.


3. Two paths in early brain development


A Yale-led study grew brain organoids (tiny 3-dimensional models of the developing brain) from the stem cells of 13 autistic boys and of their nonautistic fathers. Eight of the boys had macrocephaly, an enlarged head.


The organoids showed 2 opposite patterns. The researchers found that boys with macrocephaly had excess growth of excitatory neurons compared with their fathers, while the other boys had a deficit of the same neurons. These differences appear in the earliest weeks of brain development. Whole-genome sequencing found no rare mutations that explained them.


Macrocephaly is common in autism. A meta-analysis of 27 studies found it in about 16% of autistic people, and the Yale team cites roughly 20%.


Why it matters: if autism can arise from opposite imbalances, a drug that helps one group could do nothing, or harm, in the other. The lead investigator suggested this could help explain why autism drug trials keep failing. Organoids are a research tool, not a diagnostic test, and this was a small study of boys only.


The practical point for parents is still early identification. Signs of autism can appear by 12 to 18 months of age, sometimes earlier. If you notice them, ask your child's health care provider about screening.


4. Inflammation and the developing cerebellum


Early-life inflammation is an established risk factor for autism and schizophrenia, but how it affects the human brain has been unclear. A University of Maryland study used single-cell genetic sequencing on postmortem cerebellum tissue from children aged 1 to 5 years. It compared children who died while experiencing inflammation with children who died in accidents.


The cerebellum coordinates movement and also contributes to thinking, language, and emotional regulation. In the children with inflammation, 2 types of cerebellar neurons, Purkinje and Golgi neurons, showed the largest changes in gene activity. Those changes overlapped with normal maturation and with genes linked to neurodevelopmental conditions. The authors suggest inflammation may shut down developmental gene programs too early.


This study identifies cells to watch, not a treatment. It adds a cell-by-cell map of how inflammation may alter the young human cerebellum.


What these studies add up to


Autism has many biological paths: genes, early brain development, the immune system, and the gut all play a part, and they differ from one child to the next. That is why there is no single treatment and why one-size-fits-all claims deserve skepticism.


A word of caution. Research like this gets turned into products quickly. Talk with your child's clinician before trying any supplement, diet, or "gut cure," and don't try a fecal transplant outside a clinical trial. Evidence-based supports, such as speech, occupational, and developmental therapies, remain the foundation.


For a comprehensive book on autism and how to navigate the service system, see my book. All proceeds go to autism research.


Sources


Ament SA, Cortes-Gutierrez M, Herb BR, et al. A single-cell genomic atlas for maturation of the human cerebellum during early childhood. Sci Transl Med. 2023;15(721):eade1283. doi:10.1126/scitranslmed.ade1283


Hathaway B. Yale scientists reveal two paths to autism in the developing brain. Yale News. August 10, 2023. Accessed November 18, 2026. https://news.yale.edu/2023/08/10/yale-scientists-reveal-two-paths-autism-developing-brain


Head size parts autism into two major subtypes. The Transmitter. Accessed November 18, 2026. https://www.thetransmitter.org/spectrum/head-size-parts-autism-into-two-major-subtypes/


Jourdon A, Wu F, Mariani J, et al. Modeling idiopathic autism in forebrain organoids reveals an imbalance of excitatory cortical neuron subtypes during early neurogenesis. Nat Neurosci. 2023;26(9):1505-1515. doi:10.1038/s41593-023-01399-0


Morton JT, Jin DM, Mills RH, et al. Multi-level analysis of the gut-brain axis shows autism spectrum disorder-associated molecular and microbial profiles. Nat Neurosci. 2023;26(7):1208-1217. doi:10.1038/s41593-023-01361-0


National Institute of Child Health and Human Development. When do children usually show symptoms of autism? Accessed November 18, 2026. https://www.nichd.nih.gov/health/topics/autism/conditioninfo/symptoms-appear


Power SD, Stewart E, Zielke LG, et al. Immune activation state modulates infant engram expression across development. Sci Adv. 2023;9(45):eadg9921. doi:10.1126/sciadv.adg9921


Sacco R, Gabriele S, Persico AM. Head circumference and brain size in autism spectrum disorder: a systematic review and meta-analysis. Psychiatry Res. 2015;234(2):239-251. doi:10.1016/j.pscychresns.2015.08.016


Shaw KA, Williams S, Patrick ME, et al. Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years—Autism and Developmental Disabilities Monitoring Network, 16 sites, United States, 2022. MMWR Surveill Summ. 2025;74(2):1-22. doi:10.15585/mmwr.ss7402a1


Stewart E, Zielke LG, de Boer AR, Boulaire GG, Power SD, Ryan TJ. Microglial activity during postnatal development is required for infantile amnesia in mice. PLoS Biol. 2026;24(1):e3003538. doi:10.1371/journal.pbio.3003538


Tweedie-Cullen RY, Leong K, Wilson BC, et al. Protocol for the Gut Bugs in Autism Trial: a double-blind randomised placebo-controlled trial of faecal microbiome transfer for the treatment of gastrointestinal symptoms in autistic adolescents and adults. BMJ Open. 2024;14(2):e074625. doi:10.1136/bmjopen-2023-074625


Yap CX, Henders AK, Alvares GA, et al. Autism-related dietary preferences mediate autism-gut microbiome associations. Cell. 2021;184(24):5916-5931.e17. doi:10.1016/j.cell.2021.10.015


Zeidan J, Fombonne E, Scorah J, et al. Global prevalence of autism: a systematic review update. Autism Res. 2022;15(5):778-790. doi:10.1002/aur.2696



Comments


bottom of page